Pantoprazole Sodium Patent Expiration
Pantoprazole Sodium was first introduced by Wyeth Pharmaceuticals Llc
Pantoprazole Sodium Patents
Given below is the list of patents protecting Pantoprazole Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Protonix |
US7544370 (Pediatric) | Pantoprazole multiparticulate formulations | Dec 07, 2026 | Wyeth Pharms |
| Protonix | US7544370 | Pantoprazole multiparticulate formulations | Jun 07, 2026 | Wyeth Pharms |
| Protonix |
US7550153 (Pediatric) | Pantoprazole multiparticulate formulations | Mar 30, 2025 | Wyeth Pharms |
| Protonix |
US7553498 (Pediatric) | Pantoprazole multiparticulate formulations | Mar 30, 2025 | Wyeth Pharms |
| Protonix |
US7838027 (Pediatric) | Pantoprazole multiparticulate formulations | Mar 30, 2025 | Wyeth Pharms |
| Protonix | US7550153 | Pantoprazole multiparticulate formulations |
Sep 30, 2024
(Expired) | Wyeth Pharms |
| Protonix | US7553498 | Pantoprazole multiparticulate formulations |
Sep 30, 2024
(Expired) | Wyeth Pharms |
| Protonix | US7838027 | Pantoprazole multiparticulate formulations |
Sep 30, 2024
(Expired) | Wyeth Pharms |
| Protonix Iv |
US6780881 (Pediatric) | Freeze-dried pantoprazole preparation and pantoprazole injection |
May 17, 2022
(Expired) | Wyeth Pharms |
| Protonix Iv |
US7351723 (Pediatric) | Freeze-dried pantoprazole preparation and pantoprazole injection |
May 17, 2022
(Expired) | Wyeth Pharms |
| Protonix Iv |
US8754108 (Pediatric) | Freeze-dried pantoprazole preparation and pantoprazole injection |
May 17, 2022
(Expired) | Wyeth Pharms |
| Protonix Iv | US6780881 | Freeze-dried pantoprazole preparation and pantoprazole injection |
Nov 17, 2021
(Expired) | Wyeth Pharms |
| Protonix Iv | US7351723 | Freeze-dried pantoprazole preparation and pantoprazole injection |
Nov 17, 2021
(Expired) | Wyeth Pharms |
| Protonix Iv | US8754108 | Freeze-dried pantoprazole preparation and pantoprazole injection |
Nov 17, 2021
(Expired) | Wyeth Pharms |
| Protonix |
US5997903 (Pediatric) | Oral-administration forms of a medicament containing pantoprazol |
Jun 07, 2017
(Expired) | Wyeth Pharms |
| Protonix | US5997903 | Oral-administration forms of a medicament containing pantoprazol |
Dec 07, 2016
(Expired) | Wyeth Pharms |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Pantoprazole Sodium's patents.
Latest Legal Activities on Pantoprazole Sodium's Patents
Given below is the list recent legal activities going on the following patents of Pantoprazole Sodium.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 12 Apr, 2022 | US7838027 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 01 Dec, 2021 | US8754108 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 28 Sep, 2020 | US7550153 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 28 Sep, 2020 | US7544370 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 28 Sep, 2020 | US7553498 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 20 Sep, 2019 | US7351723 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 13 Apr, 2018 | US7838027 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 30 Nov, 2017 | US8754108 |
| Email Notification Critical | 01 Jul, 2016 | US7550153 |
| Email Notification Critical | 01 Jul, 2016 | US7553498 |
Pantoprazole Sodium's Family Patents
Explore Our Curated Drug Screens
Pantoprazole Sodium Generic API Manufacturers
Several generic applications have been filed for Pantoprazole Sodium. The first generic version for Pantoprazole Sodium was by Teva Pharmaceuticals Usa Inc and was approved on Aug 2, 2007. And the latest generic version is by Graviti Pharmaceuticals Private Ltd and was approved on Jan 16, 2025.
Given below is the list of companies who have filed for Pantoprazole Sodium generic, along with the locations of their manufacturing plants worldwide.
1. ACTAVIS TOTOWA
Actavis Totowa Llc has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Actavis Totowa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet, delayed release | Prescription | ORAL | AB | Feb 7, 2011 |
| EQ 40MG BASE | tablet, delayed release | Prescription | ORAL | AB | Feb 7, 2011 |
Manufacturing Plant Locations New
Actavis Totowa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Totowa as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
2. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | for suspension, delayed release | Prescription | ORAL | AB | Feb 9, 2023 |
Manufacturing Plant Locations New
Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
3. AMNEAL PHARMS
Amneal Pharmaceuticals has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Amneal Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet, delayed release | Prescription | ORAL | AB | Jan 26, 2016 |
| EQ 40MG BASE | tablet, delayed release | Prescription | ORAL | AB | Jan 26, 2016 |
4. ANNORA PHARMA
Annora Pharma Private Ltd has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Annora Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | for suspension, delayed release | Prescription | ORAL | AB | Oct 27, 2023 |
Manufacturing Plant Locations New
Annora Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Annora Pharma as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
5. ASPIRO
Aspiro Pharma Ltd has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Aspiro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | May 18, 2022 |
Manufacturing Plant Locations New
Aspiro's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aspiro as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
6. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | tablet, delayed release | Prescription | ORAL | AB | Sep 28, 2012 |
| EQ 20MG BASE | tablet, delayed release | Prescription | ORAL | AB | Sep 28, 2012 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
7. BE PHARMS
Be Pharmaceuticals Ag has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Be Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | May 18, 2022 |
8. DEXCEL
Dexcel Pharma Technologies Ltd has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Dexcel.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | for suspension, delayed release | Prescription | ORAL | AB | Jun 16, 2023 |
Manufacturing Plant Locations New
Dexcel's manufacturing plants are situated in 1 country - Israel. Given below are the details of these plant locations as well as the firm names of Dexcel as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| Israel |
| |||||
9. DR REDDYS LABS LTD
Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet, delayed release | Prescription | ORAL | AB | Jan 19, 2011 |
| EQ 40MG BASE | tablet, delayed release | Prescription | ORAL | AB | Jan 19, 2011 |
10. EPIC PHARMA LLC
Epic Pharma Llc has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | Nov 8, 2012 |
11. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | Mar 30, 2016 |
Manufacturing Plant Locations New
Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| India |
| |||||||
12. FRESENIUS KABI USA
Fresenius Kabi Usa Llc has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | Aug 1, 2024 |
Manufacturing Plant Locations New
Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
13. GLAND PHARMA LTD
Gland Pharma Ltd has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | May 18, 2022 |
14. GRANULES
Granules India Ltd has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Granules.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | tablet, delayed release | Prescription | ORAL | AB | Dec 11, 2023 |
| EQ 20MG BASE | tablet, delayed release | Prescription | ORAL | AB | Dec 11, 2023 |
Manufacturing Plant Locations New
Granules's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Granules as present at those locations.
| Country | City | Firm Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||
| India |
| |||||||||||
15. GRAVITI PHARMS
Graviti Pharmaceuticals Private Ltd has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Graviti Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet, delayed release | Prescription | ORAL | AB | Jan 16, 2025 |
| EQ 40MG BASE | tablet, delayed release | Prescription | ORAL | AB | Jan 16, 2025 |
16. HANGZHOU ZHONGMEI
Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Hangzhou Zhongmei.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | Aug 30, 2021 |
Manufacturing Plant Locations New
Hangzhou Zhongmei's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Hangzhou Zhongmei as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| China |
| |||||
17. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | tablet, delayed release | Prescription | ORAL | AB | Sep 10, 2014 |
| EQ 20MG BASE | tablet, delayed release | Prescription | ORAL | AB | Sep 10, 2014 |
18. INGENUS PHARMS LLC
Ingenus Pharmaceuticals Llc has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Ingenus Pharms Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | tablet, delayed release | Discontinued | ORAL | N/A | Mar 1, 2019 |
19. JUBILANT GENERICS
Jubilant Generics Ltd has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Jubilant Generics.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | tablet, delayed release | Discontinued | ORAL | N/A | Aug 30, 2011 |
| EQ 20MG BASE | tablet, delayed release | Discontinued | ORAL | N/A | Aug 30, 2011 |
Manufacturing Plant Locations New
Jubilant Generics's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Jubilant Generics as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
20. KNACK
Knack Pharmaceuticals Inc has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Knack.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | May 19, 2022 |
21. L PERRIGO CO
L Perrigo Co has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by L Perrigo Co.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet, delayed release | Discontinued | ORAL | N/A | May 7, 2014 |
22. LANNETT CO INC
Lannett Co Inc has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet, delayed release | Prescription | ORAL | AB | Jan 20, 2011 |
| EQ 40MG BASE | tablet, delayed release | Prescription | ORAL | AB | Jan 20, 2011 |
23. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet, delayed release | Discontinued | ORAL | N/A | Feb 16, 2012 |
| EQ 40MG BASE | tablet, delayed release | Discontinued | ORAL | N/A | Feb 16, 2012 |
24. MANKIND PHARMA
Mankind Pharma Ltd has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Mankind Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | tablet, delayed release | Prescription | ORAL | AB | Jul 26, 2022 |
| EQ 20MG BASE | tablet, delayed release | Discontinued | ORAL | N/A | Apr 25, 2024 |
Manufacturing Plant Locations New
Mankind Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Mankind Pharma as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| India |
| |||||
25. MEITHEAL
Meitheal Pharmaceuticals Inc has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Meitheal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | Aug 29, 2022 |
26. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | tablet, delayed release | Prescription | ORAL | AB | Jan 19, 2011 |
| EQ 20MG BASE | tablet, delayed release | Prescription | ORAL | AB | Jan 19, 2011 |
27. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | May 4, 2018 |
28. ORBION PHARMS
Orbion Pharmaceuticals Private Ltd has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Orbion Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet, delayed release | Prescription | ORAL | AB | Dec 2, 2014 |
| EQ 40MG BASE | tablet, delayed release | Prescription | ORAL | AB | Dec 2, 2014 |
29. RUBICON
Rubicon Research Private Ltd has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Rubicon.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet, delayed release | Prescription | ORAL | AB | May 2, 2012 |
| EQ 40MG BASE | tablet, delayed release | Prescription | ORAL | AB | May 2, 2012 |
Manufacturing Plant Locations New
Rubicon's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Rubicon as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| Canada |
| |||||
| India |
| |||||
30. SANDOZ
Sandoz Inc has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Sandoz.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | Jul 14, 2015 |
Manufacturing Plant Locations New
Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| Austria |
| |||||
| United States |
| |||||
| Spain |
| |||||
| India |
| |||||
31. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | for suspension, delayed release | Prescription | ORAL | AB | Jun 30, 2020 |
| EQ 20MG BASE | tablet, delayed release | Discontinued | ORAL | N/A | Sep 10, 2007 |
| EQ 40MG BASE/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | Aug 19, 2019 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||
32. SUN PHARM INDS LTD
Sun Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet, delayed release | Discontinued | ORAL | N/A | May 2, 2012 |
| EQ 40MG BASE | tablet, delayed release | Discontinued | ORAL | N/A | May 2, 2012 |
33. TEVA
Teva Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Teva.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | tablet, delayed release | Discontinued | ORAL | N/A | Aug 2, 2007 |
| EQ 20MG BASE | tablet, delayed release | Discontinued | ORAL | N/A | Aug 2, 2007 |
Manufacturing Plant Locations New
Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| India |
| |||||||||
| Canada |
| |||||||||
| Czech Republic |
| |||||||||
| Ireland |
| |||||||||
| Israel |
| |||||||||
34. TORRENT PHARMS
Torrent Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Torrent Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet, delayed release | Prescription | ORAL | AB | Jan 19, 2011 |
| EQ 40MG BASE | tablet, delayed release | Prescription | ORAL | AB | Jan 19, 2011 |
35. WOCKHARDT BIO AG
Wockhardt Bio Ag has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Wockhardt Bio Ag.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet, delayed release | Prescription | ORAL | AB | Jan 19, 2011 |
| EQ 40MG BASE | tablet, delayed release | Prescription | ORAL | AB | Jan 19, 2011 |